Our first guest is Dr. David Simpson Professor of Neurology at The Icahn School of Medicine at Mount Sinai in New York City he will discuss his professional experience with diabetic nerve pain, and signs that may be ignored, and tell us what’s needed to combat this health problem. Did you know that more than 34 million Americans, just over 1 in 10 have diabetes type 1 and diabetic nerve pain? The painful symptoms associated with this nerve damage include numbness, tingling, as well as shooting or stabbing sensations that most often affect the lower extremities. For more information visit, Qutenza.
Our guest Matthew Putman, CEO of Nanotronics, LLC was a COVID-19 Patient & Co-Founder and is a Founder of a U.S. Science Technology Company helped to develop and design a device to help other Covid-19 patients who have trouble breathing and the device just received FDA Approval for Home use. He will explain how the device can help patients with the Corona Virus, how it helped him, and how one man’s personal battle with COVID-19 inspired him to help so many others facing similar challenges. https://nanotronics.co/ For more information go to Business Wire story.
Our guests today are Mazen Noureddin, MD, MHSc, the founding director of the Fatty Liver Program at Cedars-Sinai Medical Center, and Donna R. Cryer, JD, the founder, and CEO of the Global Liver Institute. Our guests will explain why patients may have more choices than they realize, and in some cases, patients may be able to get a diagnosis of their liver condition without an invasive procedure.
Mazen Noureddin, MD, MHSc, is the founding director of the Fatty Liver Program at Cedars-Sinai Medical Center. His focus is on clinical and translational research in the area of NAFLD. Dr. Noureddin has conducted more than 30 investigational clinical studies of novel treatments for NASH. In addition, he has an interest in non-invasive testing and biomarkers of the field, especially metabolomics, serum biomarkers, trainset elastography, and magnetic resonance imaging techniques. Dr. Noureddin has published in all these areas. He is a member of the Liver Forum (FDA-AASLD-Academic Colloquium), standardizing pathways to translate therapeutic agents to clinical practice.
Donna R. Cryer, JD, is the founder and CEO of the Global Liver Institute (GLI), the only patient-driven liver health non-profit operating in the US and Europe. She has channeled her personal experience as an IBD patient and 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. Donna is a graduate of Harvard-Radcliffe Colleges and Georgetown University Law Center. For more information go to the Global Liver Organization.
Our guest is Lifestyle and wellness expert Kia Malone joins us to talk about real-life barriers chronic pain patients face in accessing proper pain treatment. September is Pain Awareness Month. While we’re all so focused on the Coronavirus, we may lose sight of the number one reason people still go to the doctor… pain! The U.S. Pain Foundation states more than 50 million people in the U.S. live with chronic pain daily. For 20 million, the pain is debilitating with a cost of $635 billion a year in medical bills and lost productivity. For more information go to twitter.com/kiamalone
Our last guests are Marsha Barnes and Taylor Holgate, Ms. Barnes is a financial wellness educator and CEO/Founder, The Finance Bar (a financial education counseling site), Marsha is a financial leader and expert with over a decade of experience in financial services and is passionate about helping others on their journey to financial wellness. Through her professional and personal experiences, she has been inspired to transform the lives of others by meeting them where they are on their journey and helping them achieve a financial lifestyle that breeds confidence and security. She strongly believes individuals can live the life they deserve and is intentional about providing resources that empower clients to live life on purpose and in a way in which they have always envisioned. For more information go to The Financial Bar
Taylor Holgate, is the Director, Government Affairs, Consumer Healthcare Products Association. Ms. Holgate is responsible for developing and implementing federal lobbying strategies on behalf of CHPA and its member companies. Prior to joining CHPA, Holgate worked in the U.S. Senate where she most recently served as press secretary to Senator Richard Burr (R-N.C.) handling communications for the Senator’s personal office and the Senate Select Committee on Intelligence. Holgate also worked for the Senate Republican Policy Committee under Chairman John Barrasso (R-Wyo.) and for Senator Jeff Chiesa (R-N.J.).
Before coming to the Senate, Holgate executed successful trade association advocacy campaigns in North Carolina and worked as a legislative assistant for UPS Corporate Public Affairs. Education: B.A., the University of North Carolina at Chapel Hill. for more information go to Taylor Holgate.